Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma - Concepedia

Concepedia

Publication | Closed Access

Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma

166

Citations

17

References

2011

Year

Timothy Best, Dalin Li, Andrew D. Skol, Tomas Kirchhoff, Sarah A. Jackson, Yutaka Yasui, Louise C. Strong, Susan M. Domchek, Katherine L. Nathanson, Olufunmilayo I. Olopade,

Nature Medicine

Tumor BiologyLymphoid NeoplasiaMedicineImmunologyPathologyCancer BiologyTherapy-induced Second MalignanciesCancer GeneticsAdult T-cell Leukemia-lymphomaOncologyMalignant DiseaseImplicate Prdm1Cancer Research

References

	Year	Citations

Page 1

Page 1